If this email is not displayed correctly please click here

Healthcare & Life Sciences

21 October 2020
Rainer Herzig Reimbursement for medicine not listed in Reimbursement Code?

Austria - Preslmayr Attorneys at Law

Although Austrian social security provides for a legal entitlement to benefits in kind (ie, free administration of medicines listed in the Reimbursement Code, except for a small prescription fee), the Organisation of Austrian Social Security is reluctant to reimburse the cost of medicines not listed in the Reimbursement Code. A recent Supreme Court decision shows that this restrictive approach is supported by the Austrian courts.

Author: Rainer Herzig
Read more
Joanne van Harmelen Genetic information: a new resource to be mined?

South Africa - ENSafrica

Given that humankind originated in Africa, Africans (and South Africans in particular) have significant genetic diversity. As such, there is a potential wealth of genetic information available to be mined. Unfortunately, without effective regulation, the collection and use of African genetic information could result in the unfair exploitation of the donors of this information. Due to the asymmetrical power relationships between donors and users of genetic information, this is a sensitive issue.

Authors: Joanne van Harmelen, Ridwaan Boda, Rakhee Dullabh
Read more
Jonas Löfgren Is Swedish market for CBD oils closed?

Sweden - Westerberg & Partners Advokatbyrå Ab

In 2019 the Administrative Court prohibited several companies from selling products containing CBD. The decisions were essentially based on the finding that the use of 'CBD' in the products' names amounted to a statement which presented them as having properties which treated medical conditions. Following these decisions, the Swedish Medical Products Agency seems to have widened the definition of 'medicinal products' when it prohibited two companies from selling oils which contain CBD.

Authors: Jonas Löfgren, Måns Ullman
Read more

Recent updates

Elena Ramacciotti Patent implications of COVID-19 crisis: current solutions according to Italian law

Italy - Trevisan & Cuonzo

Author: Elena Ramacciotti
Daniel Kendziur Binding implications of notification under German Drug Act and qualification of preparation as presentation drug

Germany - Simmons & Simmons LLP

Authors: Daniel Kendziur, Fabian Huber
David Schwartz 8 important life sciences IP issues for innovators doing business in Canada

Canada - Smart & Biggar

Author: David Schwartz
Armand Aviges Suspension of decision granting Baclocur market authorisation when decision is based on compromise rather than scientific knowledge

France - Altana

Authors: Armand Aviges, Delphine Lapillonne
Amy de La Lama Telehealth privacy issues due to COVID-19

USA - Baker McKenzie

Author: Amy de La Lama
Magdalena Kotyrba Intellectual property in clinical trials

European Union - Eversheds Sutherland (International) LLP

Authors: Magdalena Kotyrba, Tobias Maier